John G. Mancini
University of Tennessee Health Science Center
7 Papers
14 Citations
John G. Mancini is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 4 publications. Previous affiliations of John G. Mancini include St. Jude Children's Research Hospital.
Chat about Author
Papers
Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer
Christopher J. DiBlasio,John B. Malcolm,Ithaar Derweesh,Jamie H. Womack,Matthew C. Kincade,John G. Mancini,Mitchell L. Ogles,Kimberly D. Lamar,Anthony L. Patterson,Robert W. Wake +9 more
TL;DR: To investigate the incidence of patient‐reported erectile and sexual dysfunction and response to treatment in men after the induction of androgen deprivation therapy (ADT) for prostate cancer, as ADT‐induced changes in serum testosterone can result in changes in libido and sexual function.
67
•Journal Article
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
Christopher J. DiBlasio,Jessica Hammett,John B. Malcolm,Beth A Judge,Jamie H. Womack,Matthew C. Kincade,Mitchell L. Ogles,John G. Mancini,Anthony L. Patterson,Robert W. Wake,Ithaar Derweesh +10 more
TL;DR: While no predictive factors were identified for de novo psychiatric illness, increasing pre-ADT PSA was associated with de noVO anxiety and overall and disease-specific survival outcomes were similar between groups.
53
Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation.
Matthew W. Wilson,Charles H. Fraga,Christine E. Fuller,Carlos Rodriguez-Galindo,John G. Mancini,Nikolaus Hagedorn,Markos Leggas,Clinton F. Stewart +7 more
TL;DR: The results show that multiple ABC transporters were present in a cohort of sporadic patients with unilateral retinoblastoma who underwent primary enucleation, and studies are planned of the expression of ABCTransporters in eyes treated by chemotherapy and/or radiation as a comparison with this group.
41
Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments.
Julia Balaguer,Matthew W. Wilson,Catherine A. Billups,John G. Mancini,Barrett G. Haik,Ibrahim Qaddoumi,Joseph D. Khoury,Carlos Rodriguez-Galindo +7 more
TL;DR: The impact of chemotherapy, focal therapies, radiation and co‐existing ocular morbidities on histology of eyes with retinoblastoma enucleated following chemoreduction is not well known.
P-28 Real-world observational study of MVASI in metastatic colorectal cancer patients in Canada: Baseline patient characteristics
Wesley Cheung,Setareh Samimi,Saleem Kassam,Bruce Colwell,P. Meyer,G. Knight,Kim Ma,Maria Eberg,John G. Mancini,M. Alemayehu,Daniel Martinez,Millicent Packalen,R. Wani,Elaine Ngan,Y Du,Naziha Inam +15 more
TL;DR: In this article , a retrospective observational chart review included adult patients who received ≥1 MVASI cycle as their first-line biologic treatment for metastatic colorectal cancer (mCRC).